ScholarLens Back to search
2010•China Modern MedicineRequires access

Clinical observation on 87 cases of benign prostatic hyperplasia in the treatment of transurethral vaporization resection

Zeng Chun-ming

Open publisher page 0 citations

Abstract

Objective:To evaluate the clinical efficacy and safety of transurethral resection of prostate(TUVP)in the treatment of benign prostatic hyperplasia(BPH).Methods:Clinical data of 87 patients with benign prostatic hyperplasia in the treatment of TUVP surgery were analyzed.Results:The operations were successful,the operative time was(53.8±21.2)min;blood loss(397.4±142.7)ml,the average amount of removed tissue(26.8±5.6)g.2 months later,the international prostate symptom score(IPSS),quality of life score(QOL),residual urine volume(RUV),maximum urinary flow rate(MFR),and average urinary flow rate(AFR)had significant difference(P0.05)compared with the preoperative.Conclusion:TUVP in the treatment of high risk is safe,effective and ideal way with less complications.

About this research paper

What this paper is about

Objective:To evaluate the clinical efficacy and safety of transurethral resection of prostate(TUVP)in the treatment of benign prostatic hyperplasia(BPH).Methods:Clinical data of 87 patients with benign prostatic hyperplasia in the treatment of TUVP surgery were analyzed.Results:The operations were successful,the operative time was(53.8±21.2)min;blood loss(397.4±142.7)ml,the average amount of removed tissue(26.8±5.6)g.2 months later,the international prostate symptom score(IPSS),quality of life score(QOL),residual urine volume(RUV),maximum urinary flow rate(MFR),and average urinary flow rate(AFR)had significant difference(P0.05)compared with the preoperative.Conclusion:TUVP in the treatment of high risk is safe,effective and ideal way with less complications.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the clinical efficacy and safety of transurethral resection of prostate(TUVP)in the treatment of benign prostatic hyperplasia(BPH).Methods:Clinical data of 87 patients with benign prostatic hyperplasia in the treatment of TUVP surgery were analyzed.Results:The operations were successful,the operative time was(53.8±21.2)min;blood loss(397.4±142.7)ml,the average amount of removed tissue(26.8±5.6)g.2 months later,the international prostate symptom score(IPSS),quality of life score(QOL),residual urine volume(RUV),maximum urinary flow rate(MFR),and average urinary flow rate(AFR)had significant difference(P0.05)compared with the preoperative.Conclusion:TUVP in the treatment of high risk is safe,effective and ideal way with less complications.

Key concepts: Medicine, Hyperplasia, Urology, Prostate, International Prostate Symptom Score, Resection, Stage (stratigraphy), Clinical efficacy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical observation on 87 cases of benign prostatic hyperplasia in the treatment of transurethral vaporization resection — Research Paper | ScholarLens